• release). AbbVie. August 1, 2024. "AbbVie announces its new CEO". EPR. Archived from the original on 2024-02-26. Retrieved 2024-02-27. "Abbvie and Tentarix...
    40 KB (3,359 words) - 06:40, 2 August 2024
  • acquisition was completed in August 2024 with Cerevel becoming a subsidiary of Abbvie. Cerevel uses novel approaches and technologies to develop its own drugs...
    9 KB (603 words) - 06:40, 2 August 2024
  • Thumbnail for Besins Healthcare
    conditions. In November 2022, Oregon Attorney General Ellen Rosenblum sued AbbVie, Abbott Laboratories, Unimed Pharmaceuticals. The lawsuit alleges that the...
    4 KB (331 words) - 10:48, 11 June 2024
  • October AbbVie's board recommended that shareholders vote against the deal. This news sent Shire's share price down over 27%; however, AbbVie would be...
    41 KB (3,016 words) - 20:43, 31 December 2023
  • Thumbnail for Atogepant
    Atogepant (category Drugs developed by AbbVie)
    days per month. Atogepant was developed by the biopharmaceutical company AbbVie. The benefits and side effects of atogepant were evaluated in two clinical...
    13 KB (808 words) - 14:35, 26 July 2024
  • Results - AbbVie News Center". news.abbvie.com. "Financial Release - AbbVie". investors.abbvie.com. "Financial Release - AbbVie". investors.abbvie.com. "Financial...
    61 KB (2,699 words) - 04:11, 10 June 2024
  • products. It split off its research-based pharmaceuticals business into AbbVie in 2013. Abbott's products include Pedialyte, Similac, BinaxNOW, Ensure...
    64 KB (5,920 words) - 13:46, 1 August 2024
  • Thumbnail for Ibrutinib
    Ibrutinib (category Drugs developed by AbbVie)
    and $825 million in milestones. Pharmacyclics was acquired by AbbVie in May 2015, and Abbvie projected global sales of US$1 billion in 2016 and $5 billion...
    29 KB (2,605 words) - 06:34, 1 July 2024
  • Allergan (category AbbVie)
    Pharmaceuticals for $40.5 billion. In June 2019, U.S. pharmaceutical company AbbVie announced it had reached an agreement to acquire Allergan for $63 billion...
    37 KB (2,790 words) - 21:20, 17 July 2024
  • and AbbVie announced an R&D collaboration focused on aging and age-related diseases such as neurodegeneration and cancer. Working together with AbbVie, Calico...
    14 KB (1,102 words) - 06:42, 3 July 2024
  • Thumbnail for Cariprazine
    Cariprazine (category Drugs developed by AbbVie)
    depressive disorder. It is being developed jointly by AbbVie and Gedeon Richter Plc, with AbbVie responsible for commercialization in the US, Canada, Japan...
    31 KB (2,618 words) - 06:03, 18 May 2024
  • Thumbnail for Doxycycline
    Doxycycline (category Drugs developed by AbbVie)
    Doxycycline is a broad-spectrum antibiotic of the tetracycline class used in the treatment of infections caused by bacteria and certain parasites. It is...
    96 KB (9,315 words) - 23:03, 9 July 2024
  • Thumbnail for Fluoxetine
    Fluoxetine (category Drugs developed by AbbVie)
    Fluoxetine, sold under the brand name Prozac, among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is used...
    119 KB (11,703 words) - 10:40, 13 June 2024
  • Thumbnail for Venetoclax
    Venetoclax (category Drugs developed by AbbVie)
    (PDUFA) date. AbbVie Inc. manufactures Venclexta. It is marketed by both Abbvie and Genentech USA, which is a member of the Roche Group. AbbVie and Genentech...
    27 KB (2,564 words) - 02:20, 16 July 2024
  • Pharmacyclics (category AbbVie)
    commercial product. In March 2015, Chicago-based biopharmaceutical firm AbbVie announced it would acquire Pharmacyclics, as well as its lead anti-cancer...
    6 KB (321 words) - 18:21, 18 December 2023
  • Adalimumab (category Drugs developed by AbbVie)
    companies, one retaining the Abbott name and the other named AbbVie. As a result, AbbVie took over development and marketing of Humira. The brand name...
    91 KB (6,895 words) - 01:51, 16 July 2024
  • Risankizumab (category Drugs developed by AbbVie)
    "AbbVie Expands Immunology Portfolio in the U.S. with FDA Approval of Skyrizi (risankizumab-rzaa) for Moderate to Severe Plaque Psoriasis". AbbVie (Press...
    13 KB (1,018 words) - 04:46, 6 July 2024
  • Thumbnail for Upadacitinib
    Upadacitinib (category Drugs developed by AbbVie)
    September 2021. "Rinvoq (Abbvie Pty Ltd)". Archived from the original on 9 November 2022. Retrieved 9 November 2022. "Rinvoq (Abbvie Pty Ltd)". Therapeutic...
    46 KB (4,534 words) - 06:57, 1 April 2024
  • Thumbnail for Lansoprazole
    Lansoprazole (category Drugs developed by AbbVie)
    Lansoprazole, sold under the brand name Prevacid among others, is a medication which reduces stomach acid. It is a proton pump inhibitor (PPI), used to...
    17 KB (1,170 words) - 16:13, 8 March 2024
  • Thumbnail for Ketorolac
    Ketorolac (category Drugs developed by AbbVie)
    Ketorolac, sold under the brand name Toradol among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain. Specifically it is recommended...
    25 KB (2,264 words) - 23:10, 26 May 2024
  • Thumbnail for Hydrocodone/paracetamol
    Hydrocodone/paracetamol (category Drugs developed by AbbVie)
    Hydrocodone/paracetamol (also known as hydrocodone/acetaminophen) is the combination of the pain medications hydrocodone and paracetamol (acetaminophen)...
    22 KB (1,892 words) - 01:28, 13 June 2024
  • Thumbnail for Cefdinir
    Cefdinir (category Drugs developed by AbbVie)
    Cefdinir, sold under the brand name Omnicef among others, is an antibiotic used to treat pneumonia, otitis media, strep throat, and cellulitis. It is a...
    11 KB (878 words) - 17:34, 8 July 2024
  • Thumbnail for Brian Singerman
    investment to date, Stemcentrx, was acquired by pharmaceutical company AbbVie in a transaction valuing the company at up to $10.2 billion. The acquisition...
    4 KB (345 words) - 22:34, 2 August 2023
  • Thumbnail for Metronidazole
    Metronidazole (category Drugs developed by AbbVie)
    Metronidazole, sold under the brand name Flagyl among others, is an antibiotic and antiprotozoal medication. It is used either alone or with other antibiotics...
    57 KB (5,264 words) - 01:44, 3 August 2024
  • Thumbnail for Botulinum toxin
    Botulinum toxin (category Drugs developed by AbbVie)
    Botulinum toxin, or botulinum neurotoxin (commonly called botox), is a highly potent neurotoxic protein produced by the bacterium Clostridium botulinum...
    116 KB (11,620 words) - 19:28, 16 July 2024
  • bispecific CD20-directed CD3 T-cell engager. Epcoritamab was co-developed by AbbVie and Genmab. Epcoritamab was approved for medical use in the United States...
    13 KB (829 words) - 06:11, 1 July 2024
  • Thumbnail for Levothyroxine
    Levothyroxine (category Drugs developed by AbbVie)
    Levothyroxine, also known as L-thyroxine, is a synthetic form of the thyroid hormone thyroxine (T4). It is used to treat thyroid hormone deficiency (hypothyroidism)...
    36 KB (3,390 words) - 12:09, 31 July 2024
  • Thumbnail for Escitalopram
    Escitalopram (category Drugs developed by AbbVie)
    Escitalopram, sold under the brand names Lexapro and Cipralex, among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI)...
    53 KB (4,935 words) - 18:47, 8 July 2024
  • Thumbnail for Citalopram
    Citalopram (category Drugs developed by AbbVie)
    Citalopram, sold under the brand name Celexa among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is used...
    48 KB (4,583 words) - 01:39, 25 May 2024
  • Thumbnail for Ritonavir
    Ritonavir (category Drugs developed by AbbVie)
    201410356. PMC 4479028. PMID 26031248. "Kaletra FAQ". AbbVie's Kaletra product information. AbbVie. 2011. Archived from the original on July 7, 2014. Retrieved...
    42 KB (3,594 words) - 02:06, 16 July 2024